Literature DB >> 2755141

Morbidity and mortality associated with intraoperative radiotherapy.

V N Avizonis1, W T Sause, R D Noyes.   

Abstract

From May 1984 through July 1988, 67 patients have been treated with intraoperative radiation therapy (IORT) at LDS Hospital. We conducted a detailed evaluation of the morbidity and mortality related to our intraoperative experience. Major complications were classified as those requiring reoperation or resulting in death. Minor complications included all others that could not be attributed to tumor growth or recurrence. Of twelve major complications, three resulted in death. Nonfatal complications included anastomotic leak (5), wound dehiscence (1), gastric outlet obstruction (1), and bowel obstruction (1). When compared with historical controls undergoing comparable surgery at this institution prior to the availability of IORT, complication rates were similar. We feel in our institution, intraoperative radiotherapy has not added to morbidity of aggressive abdominal surgery.

Entities:  

Mesh:

Year:  1989        PMID: 2755141     DOI: 10.1002/jso.2930410410

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Neoadjuvant chemotherapy for locally advanced gastric cancer: With or without radiation.

Authors:  Ai-Wen Wu; Jia-Fu Ji
Journal:  World J Gastrointest Surg       Date:  2012-02-27

2.  Treatment of adenocarcinoma of the stomach with resection, intraoperative radiotherapy, and adjuvant external beam radiation: a phase II study from Radiation Therapy Oncology Group 85-04.

Authors:  V N Avizonis; J Buzydlowski; R Lanciano; J C Owens; R D Noyes; G E Hanks
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

3.  Local radiotherapy of exposed murine small bowel: apoptosis and inflammation.

Authors:  Andrea Polistena; Louis Banka Johnson; Salomé Ohiami-Masseron; Lena Wittgren; Sven Bäck; Charlotte Thornberg; Virgil Gadaleanu; Diya Adawi; Bengt Jeppsson
Journal:  BMC Surg       Date:  2008-01-03       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.